.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J01F_MacrolidesLincosamidesAndStreptogramins.J01FA02_Spiramycin.Spiramycin

Information

Spiramycin is a macrolide antibiotic used primarily to treat infections caused by susceptible bacteria. It is notably used for the treatment of toxoplasmosis, especially in pregnant women to prevent congenital transmission. Though used in several countries, it is not approved in the United States but remains in use in parts of Europe and other locations.

Pharmacokinetics

Typical pharmacokinetics in healthy adult volunteers, oral administration.

References

1. Isla, A, et al., & Pedraz, JL (2005). [Pharmacokinetic/pharmacodynamic analysis of antibiotic therapy in dentistry and stomatology]. Enfermedades infecciosas y microbiologia clinica 23(3) 116–121. DOI:10.1157/13072159 PUBMED:https://pubmed.ncbi.nlm.nih.gov/15757581

Revisions

• 06/2025 initial generated model